Katana VentraIP

Screening (medicine)

Screening, in medicine, is a strategy used to look for as-yet-unrecognised conditions or risk markers.[1][2][3] This testing can be applied to individuals or to a whole population without symptoms or signs of the disease being screened.

Screening interventions are designed to identify conditions which could at some future point turn into disease, thus enabling earlier intervention and management in the hope to reduce mortality and suffering from a disease. Although screening may lead to an earlier diagnosis, not all screening tests have been shown to benefit the person being screened; overdiagnosis, misdiagnosis, and creating a false sense of security are some potential adverse effects of screening. Additionally, some screening tests can be inappropriately overused.[4][5] For these reasons, a test used in a screening program, especially for a disease with low incidence, must have good sensitivity in addition to acceptable specificity.[6]


Several types of screening exist: universal screening involves screening of all individuals in a certain category (for example, all children of a certain age). Case finding involves screening a smaller group of people based on the presence of risk factors (for example, because a family member has been diagnosed with a hereditary disease). Screening interventions are not designed to be diagnostic, and often have significant rates of both false positive and false negative results.


Frequently updated recommendations for screening are provided by the independent panel of experts, the United States Preventive Services Task Force.[7]

The screening programme should respond to a recognized need.

The objectives of screening should be defined at the outset.

There should be a defined target population.

There should be scientific evidence of screening programme effectiveness.

The programme should integrate education, testing, clinical services and programme management.

There should be quality assurance, with mechanisms to minimize potential risks of screening.

The programme should ensure informed consent, confidentiality and respect for personal, bodily autonomy.

The programme should promote equity and access to screening for the entire target population.

Programme evaluation should be planned from the outset.

The overall benefits of screening should outweigh the harm.

In 1968, the World Health Organization published guidelines on the Principles and practice of screening for disease, which is often referred to as the Wilson and Jungner criteria.[8] The principles are still broadly applicable today:


In 2008, with the emergence of new genomic technologies, the WHO synthesised and modified these with the new understanding as follows:


Synthesis of emerging screening criteria proposed over the past 40 years


In summation, "when it comes to the allocation of scarce resources, economic considerations must be considered alongside 'notions of justice, equity, personal freedom, political feasibility, and the constraints of current law'."[9]

Mass screening: The screening of a whole population or subgroup. It is offered to all, irrespective of the risk status of the individual.

High risk or selective screening: High risk screening is conducted only among .

high-risk people

Multiphasic screening: The application of two or more screening tests to a large population at one time, instead of carrying out separate screening tests for single diseases.

When done thoughtfully and based on research, identification of can be a strategy for medical screening.[10]

risk factors

Examples[edit]

Common programs[edit]

In many countries there are population-based screening programmes. In some countries, such as the UK, policy is made nationally and programmes are delivered nationwide to uniform quality standards. Common screening programmes include:

Medical equipment used[edit]

Medical equipment used in screening tests is usually different from equipment used in diagnostic tests as screening tests are used to indicate the likely presence or absence of a disease or condition in people not presenting symptoms; while diagnostic medical equipment is used to make quantitative physiological measurements to confirm and determine the progress of a suspected disease or condition. Medical screening equipment must be capable of fast processing of many cases, but may not need to be as precise as diagnostic equipment.

Screening can involve cost and use of medical resources on a majority of people who do not need treatment.

Adverse effects of screening procedure (e.g. stress and anxiety, discomfort, radiation exposure, chemical exposure).

Stress and anxiety caused by prolonging knowledge of an illness without any improvement in outcome. This problem is referred to as (see also below).

overdiagnosis

Stress and anxiety caused by a screening result.

false positive

Unnecessary investigation and treatment of false positive results (namely with Type I error).

misdiagnosis

A false sense of security caused by false negatives, which may delay final diagnosis (namely with Type II error).

misdiagnosis

Screening can detect medical conditions at an early stage before symptoms present while treatment is more effective than for later detection.[22] In the best of cases lives are saved. Like any medical test, the tests used in screening are not perfect. The test result may incorrectly show positive for those without disease (false positive), or negative for people who have the condition (false negative). Limitations of screening programmes can include:


Screening for dementia in the English NHS is controversial because it could cause undue anxiety in patients and support services would be stretched. A GP reported "The main issue really seems to be centred around what the consequences of a such a diagnosis is and what is actually available to help patients."[23]

[accessed October 2019] and Oxford Medicine Online

UK National Screening Committee Criteria for appraising the viability, appropriateness and effectiveness of a screening programme

ISBN 9780198805984

Raffle, Mackie, Gray Screening: evidence and practice. Oxford University Press 2019

Health Knowledge Interactive Learning Module on Screening by Angela Raffle. Last accessed October 2019.